Angiotensin II impairs glucose utilization in obese zucker rats by increasing HPA activity via an adrenal-dependent mechanism

Hormone and Metabolic Research

Volumn 45, Issue 2, 2013, Pages 173-180

  Muller Fielitz H ^a   Raasch, W ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ACTH test; adrenalectomy; insulin; obesity; renin angiotensin II system; stress

Indexed keywords

ANGIOTENSIN II; CORTICOSTERONE; CORTICOTROPIN;

ADRENAL GLAND; ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE UTILIZATION; HOMEOSTASIS; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; STRESS; TREATMENT DURATION; ZUCKER RAT;

ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; DISEASE MODELS, ANIMAL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; MALE; METABOLIC SYNDROME X; OBESITY; PITUITARY-ADRENAL SYSTEM; RANDOM ALLOCATION; RATS; RATS, ZUCKER; UP-REGULATION;

RATTUS;

EID: 84874115239     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1327679     Document Type: Article

References (36)

1. Bjorntorp P., Rosmond R. The metabolic syndrome - a neuroendocrine disorder? Br J Nutr: 2000; 83 01 S49 S57
2. Chan O., Inouye K., Riddell M. C., Vranic M., Matthews S. G. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol: 2003; 28 87 102
3. Walker B. R. Cortisol - cause and cure for metabolic syndrome? Diabet Med: 2006; 23 1281 1288
4. Karatsoreos I. N., Bhagat S. M., Bowles N. P., Weil Z. M., Pfaff D. W., McEwen B. S. Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology: 2010; 151 2117 2127
5. Munir A., Newell-Price J. Management of diabetes mellitus in Cushing's syndrome. Neuroendocrinology: 2010; 92 01 82 85
6. Saavedra J. M., Benicky J. Brain and peripheral angiotensin II play a major role in stress. Stress: 2007; 10 185 193
7. Pavlatou M. G., Mastorakos G., Lekakis I., Liatis S., Vamvakou G., Zoumakis E., Papassotiriou I., Rabavilas A. D., Katsilambros N., Chrousos G. P. Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic-pituitary-adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: preliminary results. Stress: 2008; 11 62 72
8. Raasch W., Wittmershaus C., Dendorfer A., Voges I., Pahlke F., Dodt C., Dominiak P., Jöhren O. Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Endocrinology: 2006; 147 3539 3546
9. Engeli S., Bohnke J., Gorzelniak K., Janke J., Schling P., Bader M., Luft F. C., Sharma A. M. Weight loss and the renin-angiotensin-aldosterone system. Hypertension: 2005; 45 356 362
10. Müller H., Schweitzer N., Jöhren O., Dominiak P., Raasch W. Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization. Am J Physiol Endocrinol Metab: 2007; 293 E802 E810
11. Guillaume-Gentil C., Rohner-Jeanrenaud F., Abramo F., Bestetti G. E., Rossi G. L., Jeanrenaud B. Abnormal regulation of the hypothalamo-pituitary- adrenal axis in the genetically obese fa/fa rat. Endocrinology: 1990; 126 1873 1879
12. Plotsky P. M., Thrivikraman K. V., Watts A. G., Hauger R. L. Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology: 1992; 130 1931 1941
13. Müller-Fielitz H., Lau M., Jöhren O., Stellmacher F., Schwaninger M., Raasch W. Blood Pressure Response to Angiotensin II is Enhanced in Obese Zucker Rats and is Attributed to an Aldosterone-Dependent Mechanism. Br J Pharmacol: 2012; 166 2417 2429
14. Müller H., Kröger J., Jöhren O., Szymczak S., Bader M., Dominiak P., Raasch W. Stress sensitivity is increased in transgenic rats with low brain angiotensinogen. J Endocrinol: 2010; 204 85 92
15. Miesel A., Müller-Fielitz H., Jöhren O., Vogt F. M., Raasch W. Double blockade of angiotensin II (AT(1))-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats. Br J Pharmacol: 2012; 165 2721 2735
16. Raasch W., Bartels T., Schwartz C., Häuser W., Rütten H., Dominiak P. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? J Hypertens: 2002; 20 2495 2504
17. Pedersen E. B., Danielsen H., Jensen T., Madsen M., Sorensen S. S., Thomsen O. O. Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure. Eur J Clin Invest: 1986; 16 56 60
18. Bray G. A., Stern J. S., Castonguay T. W. Effect of adrenalectomy and high-fat diet on the fatty Zucker rat. Am J Physiol: 1992; 262 E32 E39
19. Cabassi A., Coghi P., Govoni P., Barouhiel E., Speroni E., Cavazzini S., Cantoni A. M., Scandroglio R., Fiaccadori E. Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab: 2005; 90 2888 2897
20. Engeli S., Negrel R., Sharma A. M. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension: 2000; 35 1270 1277
21. Fitzsimons J. T. Angiotensin, thirst, and sodium appetite. Physiol Rev: 1998; 78 583 686
22. Clark J. B., Palmer C. J., Shaw W. N. The diabetic Zucker fatty rat. Proc Soc Exp Biol Med: 1983; 173 68 75
23. Jöhren O., Dendorfer A., Dominiak P., Raasch W. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Brain Res: 2007; 1184 160 167
24. Barseghian G., Levine R. Effect of corticosterone on insulin and glucagon secretion by the isolated perfused rat pancreas. Endocrinology: 1980; 106 547 552
25. Lambillotte C., Gilon P., Henquin J. C. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest: 1997; 99 414 423
26. Davani B., Portwood N., Bryzgalova G., Reimer M. K., Heiden T., Ostenson C. G., Okret S., Ahren B., Efendic S., Khan A. Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes. Diabetes: 2004; 53 01 S51 S59
27. Delaunay F., Khan A., Cintra A., Davani B., Ling Z. C., Andersson A., Ostenson C. G., Gustafsson J., Efendic S., Okret S. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest: 1997; 100 2094 2098
28. Chu K. Y., Lau T., Carlsson P. O., Leung P. S. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes: 2006; 55 367 374
29. Lau T., Carlsson P. O., Leung P. S. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia: 2004; 47 240 248
30. Leung K. K., Leung P. S. Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line. J Pancreas (Online): 2008; 9 290 299
31. Feldman J. M., Lebovitz H. E. Mechanism of epinephrine and serotonin inhibition of insulin release in the golden hamster in vitro. Diabetes: 1970; 19 480 486
32. Porte D. Jr, Williams R. H. Inhibition of insulin release by norepinephrine in man. Science: 1966; 152 1248 1250
33. Juan C. C., Chien Y., Wu L. Y., Yang W. M., Chang C. L., Lai Y. H., Ho P. H., Kwok C. F., Ho L. T. Angiotensin II enhances insulin sensitivity in vitro and in vivo. Endocrinology: 2005; 146 2246 2254
34. Fliser D., Schaefer F., Schmid D., Veldhuis J. D., Ritz E. Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans. Hypertension: 1997; 30 1156 1161
35. Morris A. D., Petrie J. R., Ueda S., Connell J. M., Elliott H. L., Small M., Donnelly R. Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes: 1994; 43 1445 1449
36. Djordjevic J., Cvijic G., Davidovic V. Different activation of ACTH and corticosterone release in response to various stressors in rats. Physiol Res: 2003; 52 67 72